Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Assembly Biosciences, Inc. (ASMB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.7600-0.0400 (-2.22%)
At close: 04:00PM EST
1.7500 -0.01 (-0.57%)
After hours: 07:33PM EST
Advertisement
Sign in to post a message.
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 1.78
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 1.82
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 1.99
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 1.85
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 2.16
  • P
    Paul
    Is the $9.50 target for this year 2022?
  • P
    Paul
    should pop to $7 soon
  • L
    Laurenzhe
    McHutchinson said: “We are encouraged by the data being presented at AASLD, including with our next-generation core inhibitors 3733 and 4334, and we remain confident in our belief that combination strategies centered around core inhibitors and NrtIs will one day contribute to finite, curative therapies and the elimination of HBV.” This sounds ver nebulous and indicative of numerous unknowns. What give shareholders here the idea that a buyout would be in order?
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 2.74
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 2.07
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 2.99
  • Y
    Yahoo Finance Insights
    Assembly Biosciences is down 5.39% to 1.93
  • a
    absurd
    ASMB will be brought out....bad news is, for less than $7.00/shr. ASMB has the data but needs backing from large pharmaceutical company to complete trials within two years.....on it's own, we're looking at five years, minimum, to complete research and trials.
    Neutral
  • Y
    Yahoo Finance Insights
    Assembly Biosciences is down 5.64% to 1.84
  • Y
    Yahoo Finance Insights
    Assembly Biosciences is up 5.25% to 2.31
  • A
    A
    In August 2020, the Company filed a shelf registration statement on Form S-3 with the SEC, File No. 333-248469, that became effective on September 4, 2020 (the 2020 Registration Statement). The Company may from time to time sell any combination of the securities described in the 2020 Registration Statement in one or more offerings up to an aggregate offering price of $300.0 million. In connection with the filing of the 2020 Registration Statement, the Company entered into a sales agreement under which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $100.0 million through “at-the-market” offerings (2020 ATM), which shares are included in the $300.0 million of securities registered pursuant to the 2020 Registration Statement. During the three months ended March 31, 2021, the Company sold 5,991,858 shares of common stock under the 2020 ATM, for which the Company received net proceeds of $34.1 million, after deducting commissions, fees and expenses.

    from the 10q may 6
  • T
    Tad
    $ARWR conversation
    credit David noheji on twitter: $ASMB (-37%/AH) suffers massive phase-2 failure in HBV:
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 2.22
  • Y
    Yahoo Finance Insights
    Assembly Biosciences reached an all time low at 2.25
  • S
    Surfw777
    check this in 1 week.. easy 3 dollars up. 2 months. It's over 10 dollars and buyers made over 100% Look at the float.institutional owners.. institutional buyers even on the 6th.. licensing currently.. projected licensing with their current approvals before any more results of other drugs.. insider owner/buyers... oversold levels on all measures.. sp vs book value... price targets of 45 and 30 set on the 6th.. over 100% return if the lowest worst case target occured
Advertisement
Advertisement